Sumitomo Life Insurance CO Bristol Myers Squibb CO Transaction History

Sumitomo Life Insurance CO

$5.28 Billion
Q4 2024

A detailed history of Sumitomo Life Insurance CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Sumitomo Life Insurance CO holds 8,476 shares of BMY stock, worth $507,034. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,476

Previous 22,850 62.91%

Holding current value

$507,034

Previous $1.18 Million 59.48%

% of portfolio

0.01%

Previous 0.02%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	SELL	$51.92 - $59.94 $746,298 - $861,577	-14,374 Reduced 62.91%	8,476 $479,000
Q3 2024 Oct 16, 2024	BUY	$39.66 - $51.75 $24,351 - $31,774	614 Added 2.76%	22,850 $1.18 Million
Q2 2024 Jul 19, 2024	SELL	$40.25 - $52.99 $110,083 - $144,927	-2,735 Reduced 10.95%	22,236 $923,000
Q1 2024 Apr 26, 2024	SELL	$47.98 - $54.4 $52,778 - $59,840	-1,100 Reduced 4.22%	24,971 $1.35 Million
Q4 2023 Jan 30, 2024	SELL	$48.48 - $57.85 $66,417 - $79,254	-1,370 Reduced 4.99%	26,071 $1.34 Million
Q3 2023 Oct 23, 2023	SELL	$57.89 - $64.73 $425,780 - $476,089	-7,355 Reduced 21.14%	27,441 $1.59 Million
Q2 2023 Jul 20, 2023	SELL	$63.71 - $70.74 $214,256 - $237,898	-3,363 Reduced 8.81%	34,796 $2.23 Million
Q1 2023 Apr 27, 2023	SELL	$65.71 - $74.53 $18,398 - $20,868	-280 Reduced 0.73%	38,159 $2.65 Million
Q4 2022 Jan 17, 2023	SELL	$68.48 - $81.09 $23,899 - $28,300	-349 Reduced 0.9%	38,439 $2.77 Million
Q3 2022 Oct 31, 2022	SELL	$0.13 - $76.84 $616 - $364,375	-4,742 Reduced 10.89%	38,788 $2.76 Million
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $62,235 - $68,542	857 Added 2.01%	43,530 $3.35 Million
Q1 2022 Apr 27, 2022	SELL	$61.48 - $73.72 $41,929 - $50,277	-682 Reduced 1.57%	42,673 $3.12 Million
Q4 2021 Feb 04, 2022	SELL	$53.63 - $62.52 $68,700 - $80,088	-1,281 Reduced 2.87%	43,355 $2.7 Million
Q3 2021 Oct 25, 2021	SELL	$59.17 - $69.31 $111,594 - $130,718	-1,886 Reduced 4.05%	44,636 $2.64 Million
Q2 2021 Jul 20, 2021	SELL	$61.91 - $67.42 $441,170 - $480,434	-7,126 Reduced 13.28%	46,522 $3.11 Million
Q1 2021 Apr 27, 2021	SELL	$59.34 - $66.74 $201,043 - $226,115	-3,388 Reduced 5.94%	53,648 $3.39 Million
Q4 2020 Feb 05, 2021	SELL	$57.74 - $65.43 $241,237 - $273,366	-4,178 Reduced 6.83%	57,036 $3.54 Million
Q3 2020 Oct 29, 2020	SELL	$57.43 - $63.64 $266,647 - $295,480	-4,643 Reduced 7.05%	61,214 $3.69 Million
Q2 2020 Jul 22, 2020	SELL	$54.82 - $64.09 $310,884 - $363,454	-5,671 Reduced 7.93%	65,857 $3.87 Million
Q1 2020 May 01, 2020	BUY	$46.4 - $67.43 $119,387 - $173,497	2,573 Added 3.73%	71,528 $3.99 Million
Q4 2019 Jan 24, 2020	BUY	$49.21 - $64.19 $1.2 Million - $1.57 Million	24,448 Added 54.93%	68,955 $4.43 Million
Q3 2019 Oct 24, 2019	SELL	$42.77 - $50.71 $206,707 - $245,081	-4,833 Reduced 9.8%	44,507 $2.26 Million
Q2 2019 Jul 26, 2019	BUY	$44.62 - $49.34 $88,749 - $98,137	1,989 Added 4.2%	49,340 $2.24 Million
Q1 2019 Apr 17, 2019	SELL	$45.12 - $53.8 $242,565 - $289,228	-5,376 Reduced 10.2%	47,351 $2.26 Million
Q4 2018 Jan 24, 2019	BUY	$48.76 - $63.23 $62,120 - $80,555	1,274 Added 2.48%	52,727 $2.74 Million
Q3 2018 Oct 18, 2018	SELL	$55.19 - $62.25 $48,401 - $54,593	-877 Reduced 1.68%	51,453 $3.19 Million
Q2 2018 Jul 23, 2018	BUY	$50.53 - $62.98 $106,719 - $133,013	2,112 Added 4.21%	52,330 $2.9 Million
Q1 2018 Apr 27, 2018	SELL	$59.92 - $68.98 $132,543 - $152,583	-2,212 Reduced 4.22%	50,218 $3.18 Million
Q4 2017 Feb 01, 2018	SELL	$59.94 - $65.35 $152,727 - $166,511	-2,548 Reduced 4.63%	52,430 $3.21 Million
Q3 2017 Oct 17, 2017	BUY	$55.23 - $63.74 $3.04 Million - $3.5 Million	54,978	54,978 $3.5 Million

Others Institutions Holding BMY

# of Institutions

2,760

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $127B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Life Insurance CO with notifications on news.

Account

Sumitomo Life Insurance CO Bristol Myers Squibb CO Transaction History